IBDEI0TV ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14734,1,4,0)
 ;;=4^346.51
 ;;^UTILITY(U,$J,358.3,14734,1,5,0)
 ;;=5^Migraine,Prst w/ Aura w/o Infarct
 ;;^UTILITY(U,$J,358.3,14734,2)
 ;;=^336578
 ;;^UTILITY(U,$J,358.3,14735,0)
 ;;=346.70^^89^897^77
 ;;^UTILITY(U,$J,358.3,14735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14735,1,4,0)
 ;;=4^346.70
 ;;^UTILITY(U,$J,358.3,14735,1,5,0)
 ;;=5^Migraine,Chr w/o Aura
 ;;^UTILITY(U,$J,358.3,14735,2)
 ;;=^336748
 ;;^UTILITY(U,$J,358.3,14736,0)
 ;;=780.72^^89^897^93
 ;;^UTILITY(U,$J,358.3,14736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14736,1,4,0)
 ;;=4^780.72
 ;;^UTILITY(U,$J,358.3,14736,1,5,0)
 ;;=5^Quadraplegia,Functional
 ;;^UTILITY(U,$J,358.3,14736,2)
 ;;=^336672
 ;;^UTILITY(U,$J,358.3,14737,0)
 ;;=344.00^^89^897^99
 ;;^UTILITY(U,$J,358.3,14737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14737,1,4,0)
 ;;=4^344.00
 ;;^UTILITY(U,$J,358.3,14737,1,5,0)
 ;;=5^Quadriplegia,Unspec
 ;;^UTILITY(U,$J,358.3,14737,2)
 ;;=^101908
 ;;^UTILITY(U,$J,358.3,14738,0)
 ;;=344.1^^89^897^86
 ;;^UTILITY(U,$J,358.3,14738,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14738,1,4,0)
 ;;=4^344.1
 ;;^UTILITY(U,$J,358.3,14738,1,5,0)
 ;;=5^Paraplegia NOS
 ;;^UTILITY(U,$J,358.3,14738,2)
 ;;=^90028
 ;;^UTILITY(U,$J,358.3,14739,0)
 ;;=907.2^^89^897^74
 ;;^UTILITY(U,$J,358.3,14739,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14739,1,4,0)
 ;;=4^907.2
 ;;^UTILITY(U,$J,358.3,14739,1,5,0)
 ;;=5^Late Effect of SCI
 ;;^UTILITY(U,$J,358.3,14739,2)
 ;;=^275240
 ;;^UTILITY(U,$J,358.3,14740,0)
 ;;=V12.54^^89^897^72
 ;;^UTILITY(U,$J,358.3,14740,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14740,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,14740,1,5,0)
 ;;=5^Hx of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,14740,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,14741,0)
 ;;=438.10^^89^897^14
 ;;^UTILITY(U,$J,358.3,14741,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14741,1,4,0)
 ;;=4^438.10
 ;;^UTILITY(U,$J,358.3,14741,1,5,0)
 ;;=5^CVA w/Language (late effect)
 ;;^UTILITY(U,$J,358.3,14741,2)
 ;;=^317906
 ;;^UTILITY(U,$J,358.3,14742,0)
 ;;=438.11^^89^897^3
 ;;^UTILITY(U,$J,358.3,14742,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14742,1,4,0)
 ;;=4^438.11
 ;;^UTILITY(U,$J,358.3,14742,1,5,0)
 ;;=5^CVA w/Aphasia (late effect)
 ;;^UTILITY(U,$J,358.3,14742,2)
 ;;=^317907
 ;;^UTILITY(U,$J,358.3,14743,0)
 ;;=438.13^^89^897^6
 ;;^UTILITY(U,$J,358.3,14743,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14743,1,4,0)
 ;;=4^438.13
 ;;^UTILITY(U,$J,358.3,14743,1,5,0)
 ;;=5^CVA w/Dysarthria (late effect)
 ;;^UTILITY(U,$J,358.3,14743,2)
 ;;=^338239
 ;;^UTILITY(U,$J,358.3,14744,0)
 ;;=438.14^^89^897^10
 ;;^UTILITY(U,$J,358.3,14744,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14744,1,4,0)
 ;;=4^438.14
 ;;^UTILITY(U,$J,358.3,14744,1,5,0)
 ;;=5^CVA w/Fluency (late effect)
 ;;^UTILITY(U,$J,358.3,14744,2)
 ;;=^338240
 ;;^UTILITY(U,$J,358.3,14745,0)
 ;;=438.30^^89^897^20
 ;;^UTILITY(U,$J,358.3,14745,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14745,1,4,0)
 ;;=4^438.30
 ;;^UTILITY(U,$J,358.3,14745,1,5,0)
 ;;=5^CVA w/Monoplegia Upper Arm (late effect)
 ;;^UTILITY(U,$J,358.3,14745,2)
 ;;=^317913
 ;;^UTILITY(U,$J,358.3,14746,0)
 ;;=438.31^^89^897^16
 ;;^UTILITY(U,$J,358.3,14746,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14746,1,4,0)
 ;;=4^438.31
 ;;^UTILITY(U,$J,358.3,14746,1,5,0)
 ;;=5^CVA w/Monoplegia Dominant Upper Arm
 ;;^UTILITY(U,$J,358.3,14746,2)
 ;;=^317914
 ;;^UTILITY(U,$J,358.3,14747,0)
 ;;=438.32^^89^897^19
 ;;^UTILITY(U,$J,358.3,14747,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14747,1,4,0)
 ;;=4^438.32
 ;;^UTILITY(U,$J,358.3,14747,1,5,0)
 ;;=5^CVA w/Monoplegia Nondominant Upper Arm
